Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories.
| Revenue (TTM) | $14.35B |
| Gross Profit (TTM) | $4.14B |
| EBITDA | $2.32B |
| Operating Margin | 12.20% |
| Return on Equity | 11.70% |
| Return on Assets | 5.53% |
| Revenue/Share (TTM) | $174.02 |
| Book Value | $106.39 |
| Price-to-Book | 2.94 |
| Price-to-Sales (TTM) | 1.84 |
| EV/Revenue | 2.18 |
| EV/EBITDA | 14.50 |
| Quarterly Earnings Growth (YoY) | 28.20% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $81.10M |
| Float | $80.72M |
| % Insiders | 0.35% |
| % Institutions | 101.61% |
Volatility is currently contracting
OPK's $722M BioReference asset sale to Labcorp, with a potential $150M earnout, aims to sharpen its biopharma focus and expand access to the 4Kscore Test.
Third-quarter earnings season has opened unevenly. JPMorgan, Wells Fargo and Citigroup posted missed results this week, while UnitedHealth topped forecasts for both revenue and profit.
Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla.
First lab test offered in collaboration with Thrive Global Combines Labcorp's scientific expertise with Thrive Global's behavior change approach to help consumers turn health insights into healthier daily habits Delivers insights from five key cardiometabolic health indicators paired with educational content and recommended Thrive Microsteps® BURLINGTON, N.C., Oct. 13, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Thrive 5 Health Test, the first lab test offered in collaboration with Arianna Huffington's behavior change technology company, Thrive Global.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.
LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.
Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears exaggerated by a misunderstanding of the CMS report's impact on LH's bottom line. The proposed cuts only affect Medicare's Clinical Laboratory Fee Schedule, with annual reimbursement reductions capped at 15% and final rates pending.
Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LH and any ticker you trade — then tracks every position and per-strategy win rate.
